Siemens Healthineers Expands ‘Make in India’ with Local Production of Artis One Edition X

Table of Contents

On Tuesday, April 7, 2026, Siemens Healthineers officially announced the expansion of its “Make in India” operations with the local production of the Artis One Edition X angiography system at its Bengaluru facility.

This move marks a significant milestone in India’s medical technology landscape, as the Bengaluru plant becomes a global hub for manufacturing high-end interventional imaging systems, alongside its existing production of MRI, CT, and Digital X-ray units.


The Artis One Edition X: A Universal Workhorse

The Artis One Edition X is designed as a “truly universal” system, meaning it is engineered to handle a broad mix of procedures—from routine cardiology to complex peripheral vascular interventions—in a compact footprint.

  • Imaging Excellence: Features the Megalix Cat Plus X-ray tube with flat emitter technology, allowing for high-detailed visibility of fine vessels and stents.
  • Workflow Efficiency: Equipped with StraightView technology, ensuring images always remain upright on the display regardless of the C-arm’s rotation.
  • Space-Saving Design: The system requires only 25 square meters of floor space, compared to the 45 square meters typically needed for ceiling-mounted systems, making it ideal for tier-2 and tier-3 hospitals with limited infrastructure.
  • Automation: Incorporates HeartSweep, allowing for a single-button sweep to acquire all necessary angulations for coronary diagnostics.

Strategic Rationale: Addressing the “Cath Lab Gap”

India’s cardiovascular disease (CVD) burden is rising, yet the infrastructure to treat it remains severely undersupplied.

  1. Low Density: Current data suggests India has only 1.5 to 1.75 cath labs per million people, compared to 12–15 per million in developed markets.
  2. Tier 2/3 Expansion: By manufacturing the Artis One locally, Siemens Healthineers is lowering the cost of entry for smaller hospitals, facilitating the spread of cardiac care beyond metropolitan hubs.
  3. Broad Clinical Utility: The system’s ability to treat heart disease, kidney failure (dialysis shunt revisions), and irregular rhythms makes it a high-ROI asset for multi-specialty hospitals.

Siemens Healthineers in India (2026)

The Bengaluru factory is part of a larger, integrated ecosystem that has seen over ₹1,300 crore in cumulative investment over the past five years.

AspectDetails
WorkforceOver 7,000 employees across India, including a massive R&D and software center.
PortfolioLocally manufactures MAGNETOM Free.Star (Helium-free MRI), CT scanners, and now Advanced Therapy systems.
Policy SupportThe expansion is heavily supported by the Government of India’s Production Linked Incentive (PLI) scheme for medical devices.

Disclaimer:
The information provided on this website is intended solely for general informational and educational purposes. Certain content may be generated using artificial intelligence and could contain inaccuracies or omissions; therefore, its accuracy, completeness, and reliability cannot be guaranteed. Any opinions or views expressed are those of the respective authors or sources and do not necessarily represent the official editorial position of this publication.